Questions on fecal calprotectin's usefulness as a measure of intestinal inflammation in inflammatory bowel disease (IBD) dominated the viewer chat after the opening session of Advances in Inflammatory ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Pediatric patients with ulcerative colitis who displayed a rapid drop-off of fecal calprotectin ...

Please provide your email address to receive an email when new articles are posted on . The AGA formulated 11 conditional recommendations to inform the use of biomarkers in the management of Crohn’s ...

Background: The early bacterial colonization of the intestine post partum may affect gut inflammation and risk for disease. Very low birth weight infants (VLBW, < 1500 g) are at risk for ...

Fecal calprotectin is a highly sensitive assay that measures inflammation present in the intestinal tract. Gastroenterologists are increasingly ordering fecal calprotectin to screen and monitor ...

Although not currently recommended as a formal therapeutic target in ulcerative colitis (UC) management, histologic healing is associated with improved long-term clinical outcomes. In a small ...

Clinically, the concentration of calprotectin in feces is used as a noninvasive measure of neutrophilic infiltrate in the bowel mucosa, and thus intestinal inflammation. There is no universally agreed ...

Background: Calprotectin is a calcium binding protein, abundant in neutrophils and stable in faeces. The aims of this study were to assess faecal calprotectin concentrations (f-calprotectin) in very ...

I am still haunted by my initiation to Crohn disease. My late brother Andrew, who succumbed to the illness because of a confluence of complications at 29 years-old, first manifested symptoms as a ...

Several technologies that measure the level of calprotectin in stool samples (faecal calprotectin) were evaluated, including fully quantitative laboratory-based tests, fully quantitative rapid tests ...

SAN DIEGO, Feb. 23, 2021 /PRNewswire/ -- ProciseDx Inc. announced today that it has received CE mark for its Fecal Calprotectin (Procise FCP™) point of care tests for use on the ProciseDx™ system.

SAN DIEGO, July 14, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo ...